<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6521150</article-id><article-id pub-id-type="doi">10.3390/md17040240</article-id><article-id pub-id-type="publisher-id">marinedrugs-17-00240</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Identification of the Actinomycin D Biosynthetic Pathway from Marine-Derived <italic>Streptomyces costaricanus</italic> SCSIO ZS0073</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Mengchan</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref><xref ref-type="aff" rid="af2-marinedrugs-17-00240">2</xref><xref ref-type="author-notes" rid="fn1-marinedrugs-17-00240">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Yanxi</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref><xref ref-type="aff" rid="af2-marinedrugs-17-00240">2</xref><xref ref-type="author-notes" rid="fn1-marinedrugs-17-00240">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Yunchang</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chunyan</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref><xref ref-type="aff" rid="af2-marinedrugs-17-00240">2</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Junying</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Changli</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7712-8027</contrib-id><name><surname>Ju</surname><given-names>Jianhua</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00240">1</xref><xref ref-type="aff" rid="af2-marinedrugs-17-00240">2</xref><xref rid="c1-marinedrugs-17-00240" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-marinedrugs-17-00240"><label>1</label>CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou 510301, China; <email>18696164503@163.com</email> (M.L.); <email>jiayanxi0928@163.com</email> (Y.J.); <email>xieyunchang1984@sina.com</email> (Y.X.); <email>zhchuny@foxmail.com</email> (C.Z.); <email>majunying@scsio.ac.cn</email> (J.M.); <email>lingluboxi@163.com</email> (C.S.)</aff><aff id="af2-marinedrugs-17-00240"><label>2</label>College of Oceanography, University of Chinese Academy of Sciences, Beijing 100049, China</aff><author-notes><corresp id="c1-marinedrugs-17-00240"><label>*</label>Correspondence: <email>jju@scsio.ac.cn</email>; Tel./Fax: +86-20-8902-3028</corresp><fn id="fn1-marinedrugs-17-00240"><label>&#x02020;</label><p>These authors contributed equally to this paper.</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2019</year></pub-date><volume>17</volume><issue>4</issue><elocation-id>240</elocation-id><history><date date-type="received"><day>13</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>18</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Bioactive secondary metabolites from <italic>Streptomycetes</italic> are important sources of lead compounds in current drug development. <italic>Streptomyces costaricanus</italic> SCSIO ZS0073, a mangrove-derived actinomycete, produces actinomycin D, a clinically used therapeutic for Wilm&#x02019;s tumor of the kidney, trophoblastic tumors and rhabdomyosarcoma. In this work, we identified the actinomycin biosynthetic gene cluster (BGC) <italic>acn</italic> by detailed analyses of the <italic>S. costaricanus</italic> SCSIO ZS0073 genome. This organism produces actinomycin D with a titer of ~69.8 &#x003bc;g mL<sup>&#x02212;1</sup> along with traces of actinomycin X<italic><sub>o&#x003b2;</sub></italic>. The <italic>acn</italic> cluster localized to a 39.8 kb length region consisting of 25 open reading frames (ORFs), including a set of four genes that drive the construction of the 4-methyl-3-hydroxy-anthranilic acid (4-MHA) precursor and three non-ribosomal peptide synthetases (NRPSs) that generate the 4-MHA pentapeptide semi-lactone, which, upon dimerization, affords final actinomycin D. Furthermore, the <italic>acn</italic> cluster contains four positive regulatory genes <italic>acnWU4RO</italic>, which were identified by in vivo gene inactivation studies. Our data provide insights into the genetic characteristics of this new mangrove-derived actinomycin D bioproducer, enabling future metabolic engineering campaigns to improve both titers and the structural diversities possible for actinomycin D and related analogues.</p></abstract><kwd-group><kwd>actinomycin D</kwd><kwd>biosynthetic gene cluster</kwd><kwd>biosynthesis</kwd><kwd>bioproducer</kwd><kwd><italic>Streptomyces costaricanus</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-marinedrugs-17-00240"><title>1. Introduction</title><p>Actinomycins are a group of chromopeptide lactone antibiotics. To date, 42 actinomycins have been isolated and identified from many species of <italic>Streptomyces</italic> (<xref ref-type="app" rid="app1-marinedrugs-17-00240">Supporting Information (SI), Table S1</xref>), including actinomycin D, <italic>N</italic>-demethylactinomycins, actinomycin C, actinomycin F, actinomycin Z, actinomycin G and actinomycin Y [<xref rid="B1-marinedrugs-17-00240" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-17-00240" ref-type="bibr">2</xref>,<xref rid="B3-marinedrugs-17-00240" ref-type="bibr">3</xref>] (<xref ref-type="app" rid="app1-marinedrugs-17-00240">SI, Table S1</xref>). Some actinomycin analogues, such as methylated actinomycin D [<xref rid="B4-marinedrugs-17-00240" ref-type="bibr">4</xref>], an actinomycin Z analogue having an additional oxygen bridge between the chromophore and &#x003b2;-depsipentapeptide [<xref rid="B5-marinedrugs-17-00240" ref-type="bibr">5</xref>], actinomycins D1&#x02013;D4 [<xref rid="B6-marinedrugs-17-00240" ref-type="bibr">6</xref>] and neo-actinomycins A and B [<xref rid="B7-marinedrugs-17-00240" ref-type="bibr">7</xref>], possess structurally modified cyclopeptide rings or chromophore (<xref ref-type="app" rid="app1-marinedrugs-17-00240">SI, Table S1</xref>). Initiatives to develop actinomycin analogues with superior bioactivities have been heavily rooted in precursor-directed biosynthesis [<xref rid="B8-marinedrugs-17-00240" ref-type="bibr">8</xref>]. Actinomycins, commonly employed clinically in anticancer therapeutic regimes, exhibit excellent antitumor activity. The core phenoxazinone chromophore intercalates between the stacked nucleobases at guanine/cytosine sites of DNA whereas the pentapeptide elements bind to the minor groove; these binding interactions effectively inhibit duplication and transcription processes in tumor cells [<xref rid="B9-marinedrugs-17-00240" ref-type="bibr">9</xref>]. Exemplary in this fashion, actinomycin D is a highly effective chemotherapeutic used to treat Wilm&#x02019;s kidney tumors, trophoblastic tumors and rhabdomyosarcoma [<xref rid="B2-marinedrugs-17-00240" ref-type="bibr">2</xref>]. Actinomycin D also specifically targets and down-regulates the expression of stem-cell transcription factor, Sox-2; this protein facilitates depletion of the stem-cell population resulting in the inability of breast cancer cells to initiate tumor progression [<xref rid="B10-marinedrugs-17-00240" ref-type="bibr">10</xref>]. Low doses of actinomycin D specifically activate p53-dependant transcription enhancing the activity of chemotherapeutic drug-induced killing of p53 positive human tumor cells [<xref rid="B11-marinedrugs-17-00240" ref-type="bibr">11</xref>]. Actinomycins are also able to inhibit some viruses such as the coxsackie virus B3 and HIV-1, the causative agent of AIDS [<xref rid="B12-marinedrugs-17-00240" ref-type="bibr">12</xref>,<xref rid="B13-marinedrugs-17-00240" ref-type="bibr">13</xref>]. The combination of these novel activities and potential in human health makes actinomycin D one of the most promising candidates for medicinal development campaigns. Moreover, the actinomycins often display strong antimicrobial activities. Potent antibacterial activities against human pathogens, human pathogenic fungi, as well as aquatic pathogenic bacteria are well known [<xref rid="B14-marinedrugs-17-00240" ref-type="bibr">14</xref>]. For instance, actinomycin X<sub>2</sub> kills both resting and budding spores of <italic>Bacillus megaterium</italic> and actinomycin X<italic><sub>o&#x003b2;</sub></italic> has pronounced anti-tuberculosis activities [<xref rid="B15-marinedrugs-17-00240" ref-type="bibr">15</xref>]. Notably, despite these very favorable activities, clinical applications of actinomycin D are often limited by undesirable side-effects; liver and kidney damage rank high on this list of detrimental side-effects [<xref rid="B16-marinedrugs-17-00240" ref-type="bibr">16</xref>].</p><p>Recent progress in genome research has revealed the presence of the actinomycin D biosynthetic gene cluster (BGC) in <italic>S. chrysomallus</italic>. The gene cluster was found to encompass 50 kb of contiguous DNA on the chromosome of <italic>S. chrysomallus</italic> and to contain 28 biosynthetic genes bordered on both sides by IS (Insertion Sequence) elements [<xref rid="B17-marinedrugs-17-00240" ref-type="bibr">17</xref>]. Remarkably, 9 of the genes embedded within the actinomycin D BGC have two copies, all of which are in the same order but in the opposite orientation; such an arrangement of genes within a BGC is unprecedented. Sequencing of the actinomycin BGC in <italic>S. antibioticus</italic> IMRU 3720, which produces actinomycin D, also revealed 20 genes organized into a similar framework but without gene duplicates as in the actinomycin D biosynthetic gene cluster of <italic>S. chrysomallus</italic> [<xref rid="B18-marinedrugs-17-00240" ref-type="bibr">18</xref>]. In addition, the actinomycin G BGC in <italic>S. iakyrus</italic> was identified and reported in 2013 [<xref rid="B19-marinedrugs-17-00240" ref-type="bibr">19</xref>].</p><p>A defining feature of the actinomycins is a central phenoxazinone chromophore which serves to bridge two pentapeptide lactones consisting of diverse amino acids. The pentapeptide precursor is biosynthesized by the non-ribosomal peptide synthetase (NRPS) assembly line with the 4-methyl-3-hydroxy-anthranilic acid (4-MHA) as the initiating unit [<xref rid="B20-marinedrugs-17-00240" ref-type="bibr">20</xref>,<xref rid="B21-marinedrugs-17-00240" ref-type="bibr">21</xref>]. The biosynthesis of 4-MHA differs in various actinomycin-producing strains. For example, in <italic>S. chrysomallus</italic>, <italic>Streptosporangium sibiricum</italic> and <italic>S. parvulus</italic>, tryptophan is implicated as a substrate for tryptophan-2,3-dioxygenase which primarily forms the important MHA precursor, <italic>N</italic>-formyl kynurenine (Figure 2). <italic>N</italic>-formyl kynurenine then serves as a substrate for kynurenine formamidase and kynurenine 3-monooxygenase; the actions of these two enzymes produce 3-hydroxykynurenine (3-HK) and this sequence of chemistries is apparent in all actinomycin producers. Methylation of 3-HK then affords 4-methyl-3-hydroxy-kynurenine (4-MHK). 4-MHK is then catalyzed by hydroxykynureninase to form 4-MHA. Some deviations in this chemistry are seen, however, based on the precise actinomycin producer in question. For instance, in <italic>S. antibioticus</italic>, tryptophan is converted to 3-hydroxyanthranilic acid (3-HA) which is subsequently processed by a methyltransferase to form 4-MHA [<xref rid="B22-marinedrugs-17-00240" ref-type="bibr">22</xref>].</p><p>Perhaps one of the more intriguing questions associated with actinomycin assembly has to do with the final step of actinomycin D biosynthesis and how two molecules of MHA-pentapeptide converge, via phenoxazinone assembly, to generate the intact actinomycin. Phenoxazinone synthase (PHS), a 650 aa, two copper-containing phenoloxidase, has long been theorized to mediate this final step [<xref rid="B23-marinedrugs-17-00240" ref-type="bibr">23</xref>]. Once cloned and expressed in vitro, PHS was characterized and anticipated to activate MHA-pentapeptide monomers for subsequent dimerization reactions [<xref rid="B24-marinedrugs-17-00240" ref-type="bibr">24</xref>,<xref rid="B25-marinedrugs-17-00240" ref-type="bibr">25</xref>]. However, in the actinomycin-producer <italic>S</italic>. <italic>antibioticus</italic> IMRU 3720, actinomycin D production persisted in an inactivated &#x02206;<italic>phsA</italic> mutant [<xref rid="B26-marinedrugs-17-00240" ref-type="bibr">26</xref>], suggesting that the putative phenoxazinone synthase is not essential for actinomycin assembly. Hence, the mechanism by which the two MHA-pentapeptide monomers come together to form intact actinomycins remains largely unclear.</p><p>Enabled by high quality genomic scanning and analyses, we report here the identification of a distinct 39.8 kb gene cluster from <italic>S. costaricanus</italic> SCSIO ZS0073, a previously identified actinomycin D and actinomycin X<italic><sub>o&#x003b2;</sub></italic> producer [<xref rid="B27-marinedrugs-17-00240" ref-type="bibr">27</xref>]. We have defined the gene cluster boundaries and described the organization of the complete biosynthetic gene cluster as guided by the results of gene insertions and metabolic profile analyses. Interestingly, we have discovered that, within the upstream and downstream regions of the cluster, can be found regulatory genes <italic>acnW, acnR, acnU4</italic> and <italic>acnO</italic>. Our study expands insights into how actinomycin titers and structural diversities stand to be improved via the application of combinatorial biosynthetic approaches. Holistically speaking, actinomycin analogs with reduced toxicities and improved bioactivities represent important goals for the downstream application of new knowledge reported herein.</p></sec><sec sec-type="results" id="sec2-marinedrugs-17-00240"><title>2. Results</title><sec id="sec2dot1-marinedrugs-17-00240"><title>2.1. Identification of the Actinomycin D Biosynthetic Gene Cluster</title><p>To identify the gene cluster, we sequenced the <italic>S. costaricanus</italic> SCSIO ZS0073 genomic DNA using a combination of Hiseq 4000 and PacBio smart technologies [<xref rid="B27-marinedrugs-17-00240" ref-type="bibr">27</xref>]. <italic>S. costaricanus</italic> SCSIO ZS0073 is a mangrove-derived <italic>actinomycete</italic> which produces antibacterial secondary metabolites such as fungichromin, actinomycin D and actinomycin X<italic><sub>o&#x003b2;</sub></italic> [<xref rid="B27-marinedrugs-17-00240" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-17-00240" ref-type="bibr">28</xref>]. We analyzed a 39.8 kb region containing 24 open reading frames (ORFs), suspected of coding for actinomycin D biosynthesis. We elucidated the gene organization as shown in <xref ref-type="fig" rid="marinedrugs-17-00240-f001">Figure 1</xref> and deduced its biosynthetic pathway (<xref ref-type="fig" rid="marinedrugs-17-00240-f002">Figure 2</xref>) along with assigned gene product functions as noted below in <xref rid="marinedrugs-17-00240-t001" ref-type="table">Table 1</xref>. The gene cluster has been deposited in Genbank (with the accession number of MK234849). A cosmid library of <italic>S. costaricanus</italic> SCSIO ZS0073 was constructed using the SuperCos 1 vector system and 2 positive clones (9C2, 9A7) covering the whole gene cluster were screened using targeted gene inactivations.</p></sec><sec id="sec2dot2-marinedrugs-17-00240"><title>2.2. Determination of the Actinomycin D Biosynthetic Gene Cluster Boundaries</title><p>The upstream boundary of the actinomycin D gene cluster was preliminarily determined as being between <italic>orf</italic>(&#x02212;1) and <italic>acnW</italic>; the downstream boundary was defined between <italic>acnT3</italic> and <italic>orf</italic>(+1). The <italic>orf</italic>(&#x02212;1) encodes Type VII secretion system protein EccC. Although <italic>orf</italic>(&#x02212;1) carries with it the function of enabling secretion, all the inactivation mutants of <italic>orf</italic>(&#x02212;1) failed to show any differences in actinomycin D production levels compared to wild-type (WT) (<xref ref-type="app" rid="app1-marinedrugs-17-00240">SI, Figure S7</xref>). The upstream boundary region was further delineated by a set of gene inactivations for <italic>orf</italic>(&#x02212;1), <italic>orf</italic>(&#x02212;2) and <italic>orf</italic>(&#x02212;3). None of the inactivation bearing mutants for these genes displayed discernible differences in actinomycin D biosynthesis rates or yields relative to WT producer (<xref ref-type="app" rid="app1-marinedrugs-17-00240">SI, Figure S7</xref>). Likewise, the downstream boundary was ascertained by bioinformatic analyses and the application of mutants bearing inactivated <italic>orf</italic>(+1), <italic>orf</italic>(+2), <italic>orf</italic>(+3) genes. Although <italic>orf</italic>(+1) gene encodes an <italic>N</italic>-acetyltransferase, it is shown by inactivation experiments, the mutant strains produce the same level of actinomycin D compared to wild type strains. Further evaluations proximal to the downstream boundary revealed that genes corresponding to <italic>orf</italic>(+2) and <italic>orf</italic>(+3) encode a hypothetical protein and a two-component hybrid sensor and regulator; comparative analyses of &#x02206;<italic>orf</italic>(+2) and &#x02206;<italic>orf</italic>(+3) inactivation mutants (vs. WT) revealed that neither of these genes and their respective products play a role in actinomycin D biosynthesis (<xref ref-type="app" rid="app1-marinedrugs-17-00240">SI, Figure S7</xref>).</p></sec><sec id="sec2dot3-marinedrugs-17-00240"><title>2.3. NRPS Genes for Peptide Chain Assembly in Actinomycin D Biosynthesis</title><p>Following the biosynthesis of 4-MHA, this anthranilic acid derivative, along with other amino acids, by several NRPSs ultimately affording the 4-MHA-pentapeptide halves of actinomycin (<xref ref-type="fig" rid="marinedrugs-17-00240-f002">Figure 2</xref>A). The pentapeptide is composed of five different amino acids: <sc>l</sc>-threonine, <sc>d</sc>-valine, <sc>l</sc>-proline, <sc>l</sc>-sarcosine and methyl-valine. The genes responsible for peptide chain assembly in <italic>S. costaricanus</italic> SCSIO ZS0073 are <italic>acnD</italic>, <italic>acnE</italic>, <italic>acnN1</italic>, <italic>acnN2</italic>, <italic>acnN3</italic>. AcnD was found to contain 66 amino acid residues arranged in a manner that resembles the MbtH protein. MbtH-like proteins are found in many NRPS gene clusters [<xref rid="B29-marinedrugs-17-00240" ref-type="bibr">29</xref>] and researchers have demonstrated that MbtH-like proteins participate in some adenylation reactions by tightly binding to NRPS proteins containing adenylation domains [<xref rid="B30-marinedrugs-17-00240" ref-type="bibr">30</xref>,<xref rid="B31-marinedrugs-17-00240" ref-type="bibr">31</xref>]. MbtH-like proteins, such as gene <italic>dptG</italic> in <italic>S. roseosporus</italic> participate in the biosynthesis of the cyclic lipotridecapeptide antibiotic daptomycin [<xref rid="B32-marinedrugs-17-00240" ref-type="bibr">32</xref>] and <italic>mbtH</italic> in <italic>Mycobacerium</italic> spp. responsible for the siderophore biosynthesis [<xref rid="B33-marinedrugs-17-00240" ref-type="bibr">33</xref>]. The NRPS gene <italic>acnN1</italic> encodes an adenylation domain protein and <italic>acnE</italic> encoding 4-MHA carrier protein. Two large multidomain NRPSs <italic>acnN1</italic> and <italic>acnN3</italic> are responsible for peptide chain assembly and release from the NRPS machinery. Gene deletions of <italic>acnD</italic> + <italic>acnE</italic> in combination, <italic>acnN1</italic> and <italic>acnN3</italic> were found to abolish actinomycin D biosynthesis (<xref ref-type="fig" rid="marinedrugs-17-00240-f003">Figure 3</xref>) in the mutant producers bearing these gene inactivations.</p></sec><sec id="sec2dot4-marinedrugs-17-00240"><title>2.4. Biosynthetic Genes of 4-MHA</title><p>We identified a set of genes, designated as <italic>acnG</italic>, <italic>acnH</italic>, <italic>acnL</italic> and <italic>acnM</italic>, that show high functional similarities to enzymes involved in the biosynthesis of 4-MHA, the critical building block of the actinomycin chromophore. These genes are homologous to a set of four counterparts in actinomycin-producing strains <italic>S. antibioticus</italic> IMRU3720 and <italic>S. chrysomallus</italic> [<xref rid="B17-marinedrugs-17-00240" ref-type="bibr">17</xref>,<xref rid="B18-marinedrugs-17-00240" ref-type="bibr">18</xref>]. These genes encode for arylformamidase (<italic>acnG</italic>), tryptophan-2, 3-dioxygenase (<italic>acnH</italic>), kynureninase (<italic>acnL</italic>) and methyltransferase (<italic>acnM</italic>). The gene <italic>acnM</italic> shows 88% identities with the 3-hydroxy kynurenine methyltransferase acmL, which is responsible for the methylation of 3-HK [<xref rid="B34-marinedrugs-17-00240" ref-type="bibr">34</xref>]. However, the vital step entailing kynurenine conversion to 3-hydroxykynurenine appears to be catalyzed by a kynurenine 3-monooxygenase, the gene for which is not found within the <italic>acn</italic> gene cluster. Inactivation of <italic>acnGHLM</italic> in combination, followed by metabolite analysis of the mutant strain revealed that these genes play essential roles in actinomycin D biosynthesis (<xref ref-type="fig" rid="marinedrugs-17-00240-f003">Figure 3</xref>).</p></sec><sec id="sec2dot5-marinedrugs-17-00240"><title>2.5. Regulatory and Self-Resistance Genes</title><p>We identified six genes <italic>acnW</italic>, <italic>acnU4</italic>, <italic>acnR</italic>, <italic>acnT1</italic>, <italic>acnT2</italic> and <italic>acnT3</italic> with apparent regulatory and/or protective functions. <italic>AcnR</italic> encodes a TetR family transcriptional regulator and usually acts as a transcriptional repressor or activator in many biological processes such as cell-cell communication and metabolite regulation [<xref rid="B35-marinedrugs-17-00240" ref-type="bibr">35</xref>,<xref rid="B36-marinedrugs-17-00240" ref-type="bibr">36</xref>]. TetR family transcriptional regulators belong to a one-component system and generally possess a two-domain structure composed of an N-terminal HTH DNA-binding motif and a C-terminal ligand regulatory domain. Many of these regulators control the expression of transporters, which help bacteria acclimate to their environment [<xref rid="B37-marinedrugs-17-00240" ref-type="bibr">37</xref>,<xref rid="B38-marinedrugs-17-00240" ref-type="bibr">38</xref>]. In some cases, members of the TetR family suppress the biosynthesis of antibiotics. For instance, disruption of <italic>calR3</italic>, a TetR family member in the calcimycin BGC, was found to improve calcimycin titers [<xref rid="B39-marinedrugs-17-00240" ref-type="bibr">39</xref>]. Moreover, <italic>TrdK,</italic> which shows high similarity to TetR family members and is involved in tirandamycin production from marine-derived <italic>Streptomyces</italic> sp. SCSIO 1666 was found by gene inactivations, to suppress tirandamycin biosynthesis; <italic>trdK</italic> inactivation led to dramatically improved tirandamycin titers [<xref rid="B40-marinedrugs-17-00240" ref-type="bibr">40</xref>]. The inactivation of <italic>acnR</italic> completely abolished actinomycin D production, consistent with this gene&#x02019;s essential role as a and important positive regulator of actinomycin D biosynthesis (<xref ref-type="fig" rid="marinedrugs-17-00240-f003">Figure 3</xref>, trace viii). Gene <italic>acnW</italic> is located downstream of the boundary gene <italic>orf(&#x02212;1)</italic> and appears to encode for a hypothetical protein; <italic>acnW</italic> disruption impaired, but did not abolish, production of actinomycin D. The gene <italic>acnU4</italic> also encodes a hypothetical protein and, as with <italic>acnW</italic>, inactivation of <italic>acnU4</italic> correlates to diminished actinomycin D production (<xref ref-type="fig" rid="marinedrugs-17-00240-f003">Figure 3</xref>). On the basis of these findings, AcnW and AcnU4 appear to function as positive regulators of actinomcyin D production although the structural families to which they belong are not yet apparent. <italic>AcnO</italic> encodes a LmbU-like protein. <italic>LmbU</italic> is a regulatory gene involved in licomycin biosynthesis in <italic>S. lincolnensis</italic> 78-11. It always contains a TTA codon close to the N-terminal end of its ORF. The codon is often found in genes involved in the regulation of differentiation or secondary metabolism [<xref rid="B41-marinedrugs-17-00240" ref-type="bibr">41</xref>], in neither case is a specific role in actinomycin D assembly known, <italic>S. costaricanus</italic> SCSIO ZS0073 inactivation mutant strain of &#x02206;<italic>acnO</italic> was not able to produce even trace amounts of actinomycin D (<xref ref-type="fig" rid="marinedrugs-17-00240-f003">Figure 3</xref>, traces ix). Thus, <italic>acnO</italic> might serve as a positive regulator in actinomycin D biosynthetic pathway.</p><p>Beyond these gene&#x02013;function correlations, we also identified three putative transporter genes <italic>acnT1</italic>, <italic>acnT2</italic> and <italic>acnT3</italic>. The <italic>acnT1</italic> gene is predicted to encode an ATP-binding cassette (ABC) transporter which uses the energy of ATP to transport molecules through the membrane. Bioinformatics analyses suggest that <italic>acnT2</italic> encodes a multidrug ABC transporter permease whereas <italic>acnT3</italic> encodes a UvrA-like protein, which is a DNA binding protein involved in the excision repair of DNA. Somewhat surprisingly, inactivations of <italic>acnT1 acnT2</italic> and <italic>acnT3</italic> all produced mutant strains able to generate actinomycin D with efficiencies rivaling those seen with the WT producer (<xref ref-type="fig" rid="marinedrugs-17-00240-f003">Figure 3</xref>). Consequently, we concluded that these three transporter genes are not necessary in actinomycin D biosynthesis.</p></sec><sec id="sec2dot6-marinedrugs-17-00240"><title>2.6. Nonessential Genes of Unknown within the acn Cluster</title><p>The BGC for actinomycin D in <italic>S. costaricanus</italic> SCSIO ZS0073 houses a number of genes not associated with actinomycin D assembly. For instance, close to the upstream boundary reside genes <italic>acnA</italic> and <italic>acnB;</italic> all of these encode for hypothetical proteins. Additionally, <italic>acnU1</italic>, <italic>acnU2</italic>, <italic>acnU3</italic> also encode for proteins whose functions have not been deciphered and whose roles in actinomycin D construction appear nonessential. Inactivations for all these genes have no impact on actinomycin D biosynthesis relative to WT production efficiencies (<xref ref-type="fig" rid="marinedrugs-17-00240-f004">Figure 4</xref>). Bioinformatics have revealed that a<italic>cnC</italic> resides between <italic>acnU2</italic> and <italic>acnU3</italic> and codes for an acyl-CoA dehydrogenase. This gene&#x02019;s inactivation also appears to have no impact upon actinomycin D synthesis compared to the WT strain. This too is the case for <italic>acnQ</italic>. Located downstream of the <italic>acnR</italic>, <italic>acnQ</italic> was proposed, based on bioinformatics, to code for a siderophore-interacting protein. Such small molecule siderophore-interacting systems often constitute transport systems by which microbes control intracellular concentrations of specific secondary metabolites. As with the other genes noted however, inactivation of <italic>acnQ</italic> was found to have no bearing whatsoever on actinomycin D production compared to the WT producer (<xref ref-type="fig" rid="marinedrugs-17-00240-f004">Figure 4</xref>).</p></sec><sec id="sec2dot7-marinedrugs-17-00240"><title>2.7. Cytochrome P450 Gene acnP Is Responsible for the Hydroxylation of Proline in Actinomycin X<sub>o&#x003b2;</sub></title><p>X-type actinomycins contain 4-hydroxyproline (actinomycin X<italic><sub>o&#x003b2;</sub></italic>) or 4-oxoproline (actinomycin X<sub>2</sub>) in their &#x003b2;-pentapeptide lactone rings whereas their &#x003b1;-ring contains proline. Previous studies demonstrated the importance of a 4-oxoproline synthase within the actinomycin BGC of <italic>S. antibioticus</italic>. This enzyme catalyzes proline oxidation in each of the actinomycin halves (prior to dimerization) to form 4-hydroxyproline or 4-oxoproline; condensation of each of the hydroxylated actinomycin halves affords actinomycin X<italic><sub>o&#x003b2;</sub></italic> or actinomycin X<sub>2</sub> [<xref rid="B42-marinedrugs-17-00240" ref-type="bibr">42</xref>]. Within the actinomycin BGC in <italic>S. costaricanus</italic> SCSIO ZS0073, we identified a cytochrome P450 gene, <italic>acnP</italic>, that encodes a 436 aa protein. We hypothesized that AcnP is responsible for proline hydroxylation <italic>en route</italic> to actinomycin X<italic><sub>o&#x003b2;</sub></italic>. This speculation was validated by targeted inactivation of <italic>acnP</italic>; fermentations and metabolite analyses of the &#x02206;<italic>acnP</italic> mutant revealed the complete abrogation of actinomycin X<italic><sub>o&#x003b2;</sub></italic> production and concomitant production of actinomycin D with titers rivaling those seen with the WT producer (<xref ref-type="fig" rid="marinedrugs-17-00240-f005">Figure 5</xref>). These data make clear that AcnP is responsible for the 4-oxoproline found in actinomycin X<italic><sub>o&#x003b2;</sub></italic>.</p><p>The PHS gene outside the <italic>acn</italic> cluster is not necessary for actinomycin D biosynthesis. PHS has been presumed to catalyze the oxidative condensation of two 4-MHA-pentapeptide lactone &#x0201c;monomers&#x0201d; in the last step of actinomycin D biosynthesis. Previous studies had, in fact, demonstrated that PHS is involved in a variety of enzymatic condensations of <italic>ortho</italic>-aminophenols to form phenoxazinones. Within the genome of <italic>S. costaricanus</italic> SCSIO ZS0073, we identified a <italic>phs orf</italic> encoding a 627 aa, two copper-containing phenoloxidase separated from the actinomycin biosynthetic cluster by 5.77 Mbp. This <italic>phs</italic> gene shows sequence similarity (84% identity) to <italic>phsA</italic> in <italic>S. antibioticus</italic> IMRU3720. To validate this gene&#x02019;s involvement in actinomycin D assembly, we generated a &#x02206;<italic>phs</italic> mutant strain and assessed its biosynthetic capacity relative to the WT producer. Surprisingly, <italic>phs</italic> inactivation in the <italic>S. costaricanus</italic> SCSIO ZS0073 strain had no detectable impact upon actinomycin D production relative to the WT producer (<xref ref-type="fig" rid="marinedrugs-17-00240-f004">Figure 4</xref>). This result is consistent with the previous gene inactivation result for <italic>phsA</italic> in <italic>S. antibioticus</italic> IMRU3720 [<xref rid="B26-marinedrugs-17-00240" ref-type="bibr">26</xref>] and indicated also, that for <italic>S. costaricanus</italic> SCSIO ZS0073 actinomycin D assembly does not appear to require a PHS.</p><p><italic>acnF</italic> is essential to actinomycin D biosynthesis. Within the actinomycin cluster, <italic>acnF</italic> encodes for a hypothetical protein with 212 aa. Gene inactivation for <italic>acnF</italic>, revealed that <italic>acnF</italic> is indispensable for actinomycin D construction (<xref ref-type="fig" rid="marinedrugs-17-00240-f004">Figure 4</xref>). <italic>S. costaricanus</italic> SCSIO ZS0073 inactivation mutant strain of &#x02206;<italic>acnF</italic> was not able to produce even trace amounts of actinomycin D (<xref ref-type="fig" rid="marinedrugs-17-00240-f004">Figure 4</xref>, traces x), thus showcasing the importance of its gene products to actinomycin D biosynthesis. We proposed <italic>acnF</italic> might be involved in the dimerization of the 4-MHA-pentapeptide monomer <italic>en route</italic> to actinomycin (<xref ref-type="fig" rid="marinedrugs-17-00240-f002">Figure 2</xref>). Efforts to identify the exact roles played by <italic>acnF</italic> products are currently ongoing and will be reported in due course.</p></sec></sec><sec id="sec3-marinedrugs-17-00240"><title>3. Materials and Methods</title><sec id="sec3dot1-marinedrugs-17-00240" sec-type="methods"><title>3.1. General Experimental Procedures</title><p>Reagents for polymerase chain reactions (PCR) were purchased from Takara Co. (Dalian, China) and Trans Gene Co. (Beijing, China). The plasmid kit and gel extraction kit were from Promega. Unless otherwise indicated, other biochemicals and chemicals were purchased from standard commercial sources and used without further purification. All DNA manipulations were conducted according to the standard procedures or manufactures&#x02019; instruction. DNA and aa sequence analyses were performed with the seqmen and editsequence in the Lasergene software package (DNASTAR, Madison, WI, USA). All primers and reagents used in this work were purchased from Sangong Bio-Pharm Technology Co., Ltd., Shanghai, China. </p></sec><sec id="sec3dot2-marinedrugs-17-00240"><title>3.2. Bacterial Strains, Plasmids and Culture Conditions</title><p><italic>S. costaricanus</italic> SCSIO ZS0073, a marine actinomycete isolated from the red sand park of Guangxi (China), was used to identify the actinomycin D gene cluster [<xref rid="B27-marinedrugs-17-00240" ref-type="bibr">27</xref>]. The strain and mutants were grown at 30 &#x000b0;C on ISP-2 medium (with 3% sea salt added) for cultivation. <italic>E. coli</italic> was used for DNA cloning and sequencing. <italic>E. coli</italic> ET12567/pUZ8002, which is methylation deficient, was employed as the donor cell for conjugal transfer of DNA into <italic>S. costaricanus</italic> SCSIO ZS0073. All <italic>E. coli</italic> strains were grown in liquid lysogeny broth (LB) at 37 &#x000b0;C or 30 &#x000b0;C and 200 rpm<bold>.</bold> When used, antibiotics were added at the following concentrations: chloramphenicol (Chl, 25 &#x003bc;g mL<sup>&#x02212;1</sup>), apramycin (Apr, 50 &#x003bc;g mL<sup>&#x02212;1</sup>), kanamycin (Kan, 50 &#x003bc;g mL<sup>&#x02212;1</sup>), ampicillin (Amp, 100 &#x003bc;g mL<sup>&#x02212;1</sup>). The plasmids SuperCos 1 and pIJ773 were used for <italic>S. costaricanus</italic> SCSIO ZS0073 genomic library construction and the <italic>aac(3)IV-oriT</italic> resistance gene amplifying, respectively.</p></sec><sec id="sec3dot3-marinedrugs-17-00240"><title>3.3. Whole Genome Scanning and Sequence Analysis</title><p><italic>S. costaricanus</italic> SCSIO ZS0073 genomic DNA was isolated according to the protocol with slight modification [<xref rid="B43-marinedrugs-17-00240" ref-type="bibr">43</xref>]<bold>.</bold> Whole-genome scanning was achieved using both 454 and Solexa technology at Macrogen (Seoul, Korea). Assembly, annotation and bioinformatics analyses allowed us to define the correct contiguous fragments corresponding to the acn cluster. Assignments of ORFs and their functional predictions were accomplished using FramePlot 4.0 (<uri xlink:href="http://nocardia.bih.go.jp/fp4">http://nocardia.bih.go.jp/fp4</uri>) and Blast (<uri xlink:href="http://blast.ncbi.nlm.nih.gov/">http://blast.ncbi.nlm.nih.gov/</uri>) software packages.</p></sec><sec id="sec3dot4-marinedrugs-17-00240"><title>3.4. Genomic Library Construction and Screening</title><p>Genomic DNA was partially digested with Sau3AI and 30&#x02013;40 kb fragments were ligated into XbaI/BamHI digested and dephosphorylated SuperCos 1. The resulting ligation mixture was packaged with Gigapack III gold and transduced into <italic>E. coli</italic> LE392 to generate the genomic library, according to the manufacturer instructions.</p></sec><sec id="sec3dot5-marinedrugs-17-00240"><title>3.5. Inactivation of S. costaricanus SCSIO ZS0073 by &#x003bb;-RED-Mediated PCR-Targeting Mutagenesis</title><p>Targeted genes in the <italic>S. costaricanus</italic> SCSIO ZS0073 biosynthetic gene cluster were inactivated using &#x003bb;-mediated PCR-targeting methodology [<xref rid="B44-marinedrugs-17-00240" ref-type="bibr">44</xref>]. Two cosmids were used to disrupt target genes. An apramycin resistance cassette <italic>aac(3)IV-oriT</italic> fragment obtained by PCR (digested pIJ773 was used as template), with primer pairs containing 39-nucleotide extensions derived from the 5&#x02032;- and 3&#x02032;-ends of the targeted genes, was used to replace an internal region of each of the targeted genes. Each of the mutated genes was verified by PCR with primers designed to be 10&#x02013;300 bp outside of the disruption region, with verification by restriction enzyme digestion. The constructed mutated cosmids were introduced into non-methylating <italic>E. coli</italic> ET12567/pUZ8002 for conjugal transfer. For conjugation, harvested <italic>S. costaricanus</italic> SCSIO ZS0073 spores were suspended in TSB medium and incubated for 3&#x02013;5 h at 28 &#x000b0;C and 200 rpm after heating for 10 min at 50 &#x000b0;C. The culture was then centrifuged to harvest the germinated spores as the conjugation recipients. At the same time, LB supplied with Kan (50 &#x003bc;g mL<sup>&#x02212;1</sup>), Chl (25 &#x003bc;g mL<sup>&#x02212;1</sup>) and Apr (100 &#x003bc;g mL<sup>&#x02212;1</sup>) was inoculated with <italic>E. coli</italic> ET12567/pUZ8002 containing each mutated cosmid. After the culture OD<sub>600</sub> increased to 0.6&#x02013;0.8, the cells were harvested, washed three times with LB, resuspended in 500 &#x003bc;L LB medium and mixed with the previously germinated spores. The mixture was plated on modified ISP-4 medium containing MgCl<sub>2</sub> (60 mM). The plates ware incubated at 28 &#x000b0;C for 18&#x02013;20 h, then each plate was covered with sterile deionized water (1 mL), trimethoprim stock solution (Tmp, 30 &#x003bc;L, 50 mg mL<sup>&#x02212;1</sup>) and Apr stock solution (25 &#x003bc;L, 50 mg mL<sup>&#x02212;1</sup>). Finally, all plates were incubated at 28 &#x000b0;C for an additional 6&#x02013;7 days until exconjugants appeared. Double-crossover mutants were primarily selected on the basis of Kan<sup>S</sup>Apr<sup>R</sup> phenotypes and the desired double crossover mutants were further verified by PCR with primers listed in <xref ref-type="app" rid="app1-marinedrugs-17-00240">Table S3 (SI)</xref>.</p></sec><sec id="sec3dot6-marinedrugs-17-00240"><title>3.6. Fermentation and Analysis of S. costaricanus SCSIO ZS0073 WT and Mutant Strains</title><p><italic>S. costaricanus</italic> SCSIO ZS0073 WT and mutant strains were inoculated into 250 mL flasks with 50 mL liquid ISP-2 medium and incubated on a rotary shaker at 28 &#x000b0;C, 200 rpm. After 7 days fermentation, each of the 50 mL cultures was added to 100 mL butanone and then vigorously mixed for 30 min. The butanone phase was separated and then evaporated to dryness to yield a residue. The residue was dissolved in 2 mL methanol and centrifuged and the resulting supernatant then subjected to HPLC analysis. Analytical HPLC was performed on an Agilent 1260 HPLC system (Agilent Technologies Inc., USA) equipped with a binary pump and a diode array detector using a Phenomenex Prodigy ODS column (150 &#x000d7; 4.60 mm, 5 &#x003bc;m) with UV detection at 254 nm. The mobile phase was comprised of solvents A and B. Solvent A consisted of 15% CH<sub>3</sub>CN in water supplemented with 0.1% TFA whereas solvent B consisted of 85% CH<sub>3</sub>CN in water supplemented with 0.1% TFA. Samples were eluted with a linear gradient from 5% to 90% solvent B in 20 min, followed by 9&#x02013;100% solvent B for 5 min, then eluted with 100% solvent B for 3 min, at a flow rate of 1 mL/min and UV detection at 254 nm. LC-ESI-MS data were obtained using an amaZon SL ion trap mass spectrometer (Bruker, Billerica, MA, USA). The mobile phase comprises solvents A and B. Solvent A consists of 100% ddH<sub>2</sub>O supplemented with 0.1% methanoic acid whereas solvent B consists of 100% CH<sub>3</sub>CN supplemented with 0.1% methanoic acid. Samples were eluted with a linear gradient from 5 % to 90% solvent B in 20 min, followed by 9&#x02013;100% solvent B for 5 min, then eluted with 100% solvent B for 3 min, at a flow rate of 1 mL/min and UV detection at 254 nm.</p></sec></sec><sec sec-type="conclusions" id="sec4-marinedrugs-17-00240"><title>4. Conclusions</title><p>Actinomycin D is a vital antibiotic in the treatment of Wilms&#x02019; tumor, trophoblastic tumors and rhabdonyosarcoma. Here, we have identified and characterized a new actinomycin D BGC (<italic>acn</italic>) in marine derived producer <italic>S. costaricanus</italic> SCSIO ZS0073 by carrying out whole genome sequencing and systematic gene disruptions. Relative to the gene cluster for actinomycin of <italic>S. chrysomallus</italic> and <italic>S. antibioticus</italic> IMRU3720, the size of the <italic>acn</italic> cluster in <italic>S. costaricanus</italic> SCSIO ZS0073 is smaller. In silico analysis, gene inactivation and metabolomics data enabled us to deduce the biosynthetic pathway leading to actinomycin D in <italic>S. costaricanus</italic> SCSIO ZS0073. We furthermore determined the <italic>acn</italic> cluster boundaries and elucidated the functions of positive regulatory genes <italic>acnWU4RO</italic> along with the cytochrome P450 gene <italic>acnP</italic> which is responsible for installing the 4-oxoproline seen in actinomycin X<italic><sub>o</sub><sub>&#x003b2;</sub></italic>. The discovery of this new actinomycin BGC advances initiatives to engineer new actinomycin D analogues for clinical use and to explore the still elusive mechanism of actinomycin 4-MHA-pentapeptide monomer dimerization <italic>en route</italic> to intact actinomycins.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Aijun Sun, Xiaohong Zheng, Yun Zhang, Xuan Ma and Zhihui Xiao, in the analytical facility center of the SCSIO for recording MS and NMR data.</p></ack><app-group><app id="app1-marinedrugs-17-00240"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/1660-3397/17/4/240/s1">https://www.mdpi.com/1660-3397/17/4/240/s1</uri>, Figures S1&#x02013;S28. Disruption genes in actinomycin biosynthetic gene cluster in WT <italic>S. costaricanus</italic> SCSIO ZS0073 via PCR-targeting. Table S1, Structure of actinomycins; Table S2, Strains and plasmids used in this study.</p><supplementary-material content-type="local-data" id="marinedrugs-17-00240-s001"><media xlink:href="marinedrugs-17-00240-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>J.J. designed experiments. M.L. and Y.J. performed the experiments. Y.X., Z.C., J.M., C.S. and J.J. analyzed data. M.L. and J.J. wrote the manuscript. All authors read and approved the final manuscript.</p></notes><notes><title>Funding</title><p>This study was supported, in part, by the National Natural Science Foundation of China (U1501223, U1706206, 81425022), the Chinese Academy of Sciences (XDA13020302) and Natural Science Foundation of Guangdong Province (2016A030312014).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-marinedrugs-17-00240"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitzer</surname><given-names>J.</given-names></name><name><surname>Streibel</surname><given-names>M.</given-names></name><name><surname>Langer</surname><given-names>H.J.</given-names></name><name><surname>Grond</surname><given-names>S.</given-names></name></person-group><article-title>First Y-type actinomycins from <italic>Streptomyces</italic> with divergent structure-activity relationships for antibacterial and cytotoxic properties</article-title><source>Org. Biomol. Chem.</source><year>2009</year><volume>7</volume><fpage>444</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1039/B815689A</pub-id><?supplied-pmid 19156308?><pub-id pub-id-type="pmid">19156308</pub-id></element-citation></ref><ref id="B2-marinedrugs-17-00240"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollstein</surname><given-names>U.</given-names></name></person-group><article-title>Actinomycin. Chemistry and mechanism of action</article-title><source>Chem. Rev.</source><year>1974</year><volume>74</volume><fpage>625</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1021/cr60292a002</pub-id></element-citation></ref><ref id="B3-marinedrugs-17-00240"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W.L.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Elshahawi</surname><given-names>S.I.</given-names></name><name><surname>Ponomareva</surname><given-names>L.V.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>McErlean</surname><given-names>M.R.</given-names></name><name><surname>Cui</surname><given-names>Z.</given-names></name><name><surname>Arlinghaus</surname><given-names>A.L.</given-names></name><name><surname>Thorson</surname><given-names>J.S.</given-names></name><name><surname>Van Lanen</surname><given-names>S.G.</given-names></name></person-group><article-title>Antibacterial and cytotoxic actinomycins Y6&#x02013;Y9 and Zp from <italic>Streptomyces</italic> sp. strain G&#x000f6;-GS12</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>2731</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00742</pub-id><?supplied-pmid 27736087?><pub-id pub-id-type="pmid">27736087</pub-id></element-citation></ref><ref id="B4-marinedrugs-17-00240"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Qin</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Bian</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name></person-group><article-title>Methylated actinomycin D, a novel actinomycin D analog induces apoptosis in HepG2 cells through Fas- and mitochondria-mediated pathways</article-title><source>Mol. Carcinog.</source><year>2013</year><volume>52</volume><fpage>983</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1002/mc.21943</pub-id><?supplied-pmid 22821714?><pub-id pub-id-type="pmid">22821714</pub-id></element-citation></ref><ref id="B5-marinedrugs-17-00240"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>Y.T.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>R.T.</given-names></name><name><surname>Huang</surname><given-names>S.X.</given-names></name></person-group><article-title>A new actinomycin Z analogue with an additional oxygen bridge between chromophore and &#x003b2;-depsipentapeptide from <italic>Streptomyces</italic> sp. KIB-H714</article-title><source>Nat. Prod. Res.</source><year>2018</year><volume>2</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1080/14786419.2018.1443097</pub-id></element-citation></ref><ref id="B6-marinedrugs-17-00240"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>W.H.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Z.Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>J.B.</given-names></name><name><surname>Gui</surname><given-names>Y.H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>B.P.</given-names></name><name><surname>Lin</surname><given-names>H.W.</given-names></name></person-group><article-title>Anti-MRSA actinomycins D1&#x02013;D4 from the marine sponge-associated <italic>Streptomyces</italic> sp. LHW52447</article-title><source>Tetrahedron</source><year>2018</year><volume>74</volume><fpage>5914</fpage><lpage>5919</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2018.08.023</pub-id></element-citation></ref><ref id="B7-marinedrugs-17-00240"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>C.L.</given-names></name><name><surname>You</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Gan</surname><given-names>M.</given-names></name></person-group><article-title>Neo-actinomycins A and B, natural actinomycins bearing the 5 H-oxazolo [4-b] phenoxazine chromophore, from the marine-derived <italic>Streptomyces</italic> sp. IMB094</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>3591</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-03769-8</pub-id><pub-id pub-id-type="pmid">28620204</pub-id></element-citation></ref><ref id="B8-marinedrugs-17-00240"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitzer</surname><given-names>J.</given-names></name><name><surname>Gesheva</surname><given-names>V.</given-names></name><name><surname>Zeeck</surname><given-names>A.</given-names></name></person-group><article-title>Actinomycins with altered threonine units in the <italic>&#x003b2;</italic>-peptidolactone</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>1153</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1021/np060063g</pub-id><?supplied-pmid 16933866?><pub-id pub-id-type="pmid">16933866</pub-id></element-citation></ref><ref id="B9-marinedrugs-17-00240"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>Y.S.</given-names></name><name><surname>Tseng</surname><given-names>W.H.</given-names></name><name><surname>Chuang</surname><given-names>C.Y.</given-names></name><name><surname>Hou</surname><given-names>M.H.</given-names></name></person-group><article-title>The structural basis of actinomycin D-binding induces nucleotide flipping out, a sharp bend and a left-handed twist in CGG triplet repeats</article-title><source>Nucleic Acids Res.</source><year>2013</year><volume>41</volume><fpage>4284</fpage><lpage>4294</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt084</pub-id><pub-id pub-id-type="pmid">23408860</pub-id></element-citation></ref><ref id="B10-marinedrugs-17-00240"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>T.</given-names></name><name><surname>Nair</surname><given-names>R.R.</given-names></name><name><surname>Green</surname><given-names>R.</given-names></name><name><surname>Padhee</surname><given-names>S.</given-names></name><name><surname>Howell</surname><given-names>M.</given-names></name><name><surname>Banerjee</surname><given-names>J.</given-names></name><name><surname>Mohapatra</surname><given-names>S.S.</given-names></name><name><surname>Mohapatra</surname><given-names>S.</given-names></name></person-group><article-title>Actinomycin D down-regulates SOX2 expression and induces death in breast cancer stem cells</article-title><source>Anticancer Res.</source><year>2017</year><volume>37</volume><fpage>1655</fpage><lpage>1663</lpage><?supplied-pmid 28373426?><pub-id pub-id-type="pmid">28373426</pub-id></element-citation></ref><ref id="B11-marinedrugs-17-00240"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choong</surname><given-names>M.L.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>M.A.</given-names></name><name><surname>Lane</surname><given-names>D.P.</given-names></name></person-group><article-title>Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy</article-title><source>Cell Cycle</source><year>2009</year><volume>8</volume><fpage>2810</fpage><lpage>2818</lpage><pub-id pub-id-type="doi">10.4161/cc.8.17.9503</pub-id><?supplied-pmid 19657224?><pub-id pub-id-type="pmid">19657224</pub-id></element-citation></ref><ref id="B12-marinedrugs-17-00240"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saijets</surname><given-names>S.</given-names></name><name><surname>Ylipaasto</surname><given-names>P.</given-names></name><name><surname>Vaarala</surname><given-names>O.</given-names></name><name><surname>Hovi</surname><given-names>T.</given-names></name><name><surname>Roivainen</surname><given-names>M.</given-names></name></person-group><article-title>Enterovirus infection and activation of human umbilical vein endothelial cells</article-title><source>J. Med. Virol.</source><year>2003</year><volume>70</volume><fpage>430</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1002/jmv.10413</pub-id><pub-id pub-id-type="pmid">12767007</pub-id></element-citation></ref><ref id="B13-marinedrugs-17-00240"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rill</surname><given-names>R.L.</given-names></name><name><surname>Hecker</surname><given-names>K.H.</given-names></name></person-group><article-title>Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>3525</fpage><lpage>3533</lpage><pub-id pub-id-type="doi">10.1021/bi9530797</pub-id><pub-id pub-id-type="pmid">8639503</pub-id></element-citation></ref><ref id="B14-marinedrugs-17-00240"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Gui</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Khalaf</surname><given-names>S.M.H.</given-names></name><name><surname>Elsayed</surname><given-names>E.A.</given-names></name><name><surname>Wadaan</surname><given-names>M.A.M.</given-names></name><name><surname>Hozzein</surname><given-names>W.N.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name></person-group><article-title>Identification, bioactivity and productivity of actinomycins from the marine-derived <italic>Streptomyces heliomycini</italic></article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1147</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01147</pub-id><?supplied-pmid 28702007?><pub-id pub-id-type="pmid">28702007</pub-id></element-citation></ref><ref id="B15-marinedrugs-17-00240"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Song</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Abdel-Mageed</surname><given-names>W.M.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>C.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>N.</given-names></name><etal/></person-group><article-title>A marine-derived <italic>Streptomyces</italic> sp. MS449 produces high yield of actinomycin X<sub>2</sub> and actinomycin D with potent anti-tuberculosis activity</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>95</volume><fpage>919</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-4079-z</pub-id><?supplied-pmid 22543353?><pub-id pub-id-type="pmid">22543353</pub-id></element-citation></ref><ref id="B16-marinedrugs-17-00240"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>A.S.</given-names></name><name><surname>Couto</surname><given-names>C.G.</given-names></name><name><surname>Ayl</surname><given-names>R.D.</given-names></name><name><surname>Shank</surname><given-names>K.A.</given-names></name></person-group><article-title>Treatment of tumor-bearing dogs with actinomycin D</article-title><source>J. Vet. Intern. Med.</source><year>1994</year><volume>8</volume><fpage>236</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1111/j.1939-1676.1994.tb03224.x</pub-id><?supplied-pmid 8064663?><pub-id pub-id-type="pmid">8064663</pub-id></element-citation></ref><ref id="B17-marinedrugs-17-00240"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>U.</given-names></name><name><surname>Lang</surname><given-names>M.</given-names></name><name><surname>Crnovcic</surname><given-names>I.</given-names></name><name><surname>Pfennig</surname><given-names>F.</given-names></name><name><surname>Schauwecker</surname><given-names>F.</given-names></name></person-group><article-title>The actinomycin biosynthetic gene cluster of <italic>Streptomyces chrysomallus</italic>: A genetic hall of mirrors for synthesis of a molecule with mirror symmetry</article-title><source>J. Bacteriol.</source><year>2010</year><volume>192</volume><fpage>2583</fpage><lpage>2595</lpage><pub-id pub-id-type="doi">10.1128/JB.01526-09</pub-id><pub-id pub-id-type="pmid">20304989</pub-id></element-citation></ref><ref id="B18-marinedrugs-17-00240"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crnov&#x0010d;i&#x00107;</surname><given-names>I.</given-names></name><name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name><name><surname>Semsary</surname><given-names>S.</given-names></name><name><surname>Lang</surname><given-names>M.</given-names></name><name><surname>Kalinowski</surname><given-names>J.</given-names></name><name><surname>Keller</surname><given-names>U.</given-names></name></person-group><article-title>Genetic interrelations in the actinomycin biosynthetic gene clusters of <italic>Streptomyces antibioticus</italic> IMRU 3720 and <italic>Streptomyces chrysomallus</italic> ATCC11523, producers of actinomycin X and actinomycin C</article-title><source>Adv. Appl. Bioinform. Chem.</source><year>2017</year><volume>10</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.2147/AABC.S117707</pub-id><pub-id pub-id-type="pmid">28435299</pub-id></element-citation></ref><ref id="B19-marinedrugs-17-00240"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Tabudravu</surname><given-names>J.</given-names></name><name><surname>Rateb</surname><given-names>M.E.</given-names></name><name><surname>Annand</surname><given-names>K.J.</given-names></name><name><surname>Qin</surname><given-names>Z.</given-names></name><name><surname>Jaspars</surname><given-names>M.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>H.</given-names></name></person-group><article-title>Identification and characterization of the actinomycin G gene cluster in <italic>Streptomyces iakyrus</italic></article-title><source>Mol. Biosyst.</source><year>2013</year><volume>9</volume><fpage>1286</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1039/c3mb70081j</pub-id><pub-id pub-id-type="pmid">23567908</pub-id></element-citation></ref><ref id="B20-marinedrugs-17-00240"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfennig</surname><given-names>F.</given-names></name><name><surname>Schauwecker</surname><given-names>F.</given-names></name><name><surname>Keller</surname><given-names>U.</given-names></name></person-group><article-title>Molecular characterization of the genes of actinomycin synthetase I and of a 4-methyl-3-hydroxyanthranilic acid carrier protein involved in the assembly of the acylpeptide chain of actinomycin in <italic>Streptomyces</italic></article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>12508</fpage><lpage>12516</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.18.12508</pub-id><pub-id pub-id-type="pmid">10212227</pub-id></element-citation></ref><ref id="B21-marinedrugs-17-00240"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schauwecker</surname><given-names>F.</given-names></name><name><surname>Pfennig</surname><given-names>F.</given-names></name><name><surname>Grammel</surname><given-names>N.</given-names></name><name><surname>Keller</surname><given-names>U.</given-names></name></person-group><article-title>Construction and in vitro analysis of a new bi-modular polypeptide synthetase for synthesis of <italic>N</italic>-methylated acyl peptides</article-title><source>Chem. Biol.</source><year>2000</year><volume>7</volume><fpage>287</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(00)00103-4</pub-id><pub-id pub-id-type="pmid">10780924</pub-id></element-citation></ref><ref id="B22-marinedrugs-17-00240"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawaz</surname><given-names>F.</given-names></name><name><surname>Jones</surname><given-names>G.H.</given-names></name></person-group><article-title>Actinomycin synthesis in <italic>Streptomyces antibioticus</italic>. Purification and properties of a 3-hydroxyanthranilate 4-methyltransferase</article-title><source>J. Biol. Chem.</source><year>1988</year><volume>4</volume><fpage>4602</fpage><lpage>4606</lpage></element-citation></ref><ref id="B23-marinedrugs-17-00240"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A.W.</given-names></name><name><surname>Camara-Artigas</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Allen</surname><given-names>J.P.</given-names></name><name><surname>Francisco</surname><given-names>W.A.</given-names></name></person-group><article-title>Structure of phenoxazinone synthase from <italic>Streptomyces antibioticus</italic> reveals a new type 2 copper center</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>4378</fpage><lpage>4387</lpage><pub-id pub-id-type="doi">10.1021/bi0525526</pub-id><pub-id pub-id-type="pmid">16584173</pub-id></element-citation></ref><ref id="B24-marinedrugs-17-00240"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madu</surname><given-names>A.C.</given-names></name><name><surname>Jones</surname><given-names>G.H.</given-names></name></person-group><article-title>Molecular cloning and in vitro expression of a silent phenoxazinone synthase gene from <italic>Streptomyces lividans</italic></article-title><source>Gene</source><year>1989</year><volume>84</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(89)90502-7</pub-id><pub-id pub-id-type="pmid">2558968</pub-id></element-citation></ref><ref id="B25-marinedrugs-17-00240"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golub</surname><given-names>E.E.</given-names></name><name><surname>Ward</surname><given-names>M.A.</given-names></name><name><surname>Nishimura</surname><given-names>J.S.</given-names></name></person-group><article-title>Biosynthesis of the actinomycin chromophore: Incorporation of 3-hydroxy-4-methylanthranilic acid into actinomycins by <italic>Streptomyces antibioticus</italic></article-title><source>J. Bacteriol.</source><year>1969</year><volume>100</volume><fpage>977</fpage><lpage>984</lpage><?supplied-pmid 4187701?><pub-id pub-id-type="pmid">4187701</pub-id></element-citation></ref><ref id="B26-marinedrugs-17-00240"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>G.H.</given-names></name></person-group><article-title>Actinomycin production persists in a strain of <italic>Streptomyces antibioticus</italic> lacking phenoxazinone synthase</article-title><source>Antimicrob. Agents. Chemother.</source><year>2000</year><volume>44</volume><fpage>1322</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.1128/AAC.44.5.1322-1327.2000</pub-id><pub-id pub-id-type="pmid">10770769</pub-id></element-citation></ref><ref id="B27-marinedrugs-17-00240"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Ju</surname><given-names>J.</given-names></name></person-group><article-title>Antibacterial secondary metabolites produced by mangrove-derived actinomycete <italic>Stremptomeces costaricanus</italic> SCSIO ZS0073</article-title><source>Nat. Prod. Res. Dev.</source><year>2017</year><volume>29</volume><fpage>410</fpage><lpage>414</lpage></element-citation></ref><ref id="B28-marinedrugs-17-00240"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Ju</surname><given-names>J.</given-names></name></person-group><article-title>Identification of the fungichromin biosynthetic pathway from <italic>Streptomyces costaricanus</italic> SCSIO ZS0073</article-title><source>Chin. J. Mar. Drug</source><year>2017</year><volume>36</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B29-marinedrugs-17-00240"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>R.H.</given-names></name></person-group><article-title>Function of MbtH homologs in nonribosomal peptide biosynthesis and applications in secondary metabolite discovery</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2011</year><volume>38</volume><fpage>1747</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1007/s10295-011-1022-8</pub-id><pub-id pub-id-type="pmid">21826462</pub-id></element-citation></ref><ref id="B30-marinedrugs-17-00240"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felnagle</surname><given-names>E.A.</given-names></name><name><surname>Barkei</surname><given-names>J.J.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Podevels</surname><given-names>A.M.</given-names></name><name><surname>McMahon</surname><given-names>M.D.</given-names></name><name><surname>Drott</surname><given-names>D.W.</given-names></name><name><surname>Thomas</surname><given-names>M.G.</given-names></name></person-group><article-title>MbtH-like proteins as integral components of bacterial nonribosomal peptide synthetases</article-title><source>Biochemistry</source><year>2010</year><volume>49</volume><fpage>8815</fpage><lpage>8817</lpage><pub-id pub-id-type="doi">10.1021/bi1012854</pub-id><pub-id pub-id-type="pmid">20845982</pub-id></element-citation></ref><ref id="B31-marinedrugs-17-00240"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imker</surname><given-names>H.J.</given-names></name><name><surname>Krahn</surname><given-names>D.</given-names></name><name><surname>Clerc</surname><given-names>J.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Walsh</surname><given-names>C.T.</given-names></name></person-group><article-title><italic>N</italic>-Acylation during glidobactin biosynthesis by the tridomain nonribosomal peptide synthetase module GlbF</article-title><source>Chem. Biol.</source><year>2010</year><volume>17</volume><fpage>1077</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2010.08.007</pub-id><?supplied-pmid 21035730?><pub-id pub-id-type="pmid">21035730</pub-id></element-citation></ref><ref id="B32-marinedrugs-17-00240"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>R.H.</given-names></name></person-group><article-title>Genomics and the ancient origins of the daptomycin biosynthetic gene cluster</article-title><source>J. Antibiot.</source><year>2010</year><volume>63</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/ja.2010.82</pub-id><?supplied-pmid 20648020?><pub-id pub-id-type="pmid">20648020</pub-id></element-citation></ref><ref id="B33-marinedrugs-17-00240"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadri</surname><given-names>L.E.</given-names></name><name><surname>Sello</surname><given-names>J.</given-names></name><name><surname>Keating</surname><given-names>T.A.</given-names></name><name><surname>Weinreb</surname><given-names>P.H.</given-names></name><name><surname>Walsh</surname><given-names>C.T.</given-names></name></person-group><article-title>Identification of <italic>Mycobacterium tuberculosis</italic> gene cluster encoding the biosynthetic enzymes for assembly of the virulence conferring siderophore mycobactin</article-title><source>Chem. Biol.</source><year>1998</year><volume>5</volume><fpage>631</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(98)90291-5</pub-id><pub-id pub-id-type="pmid">9831524</pub-id></element-citation></ref><ref id="B34-marinedrugs-17-00240"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crnov&#x0010d;i&#x00107;</surname><given-names>I.</given-names></name><name><surname>S&#x000fc;ssmuth</surname><given-names>R.</given-names></name><name><surname>Keller</surname><given-names>U.</given-names></name></person-group><article-title>Aromatic C-methyltransferases with antipodal stereoselectivity for structurally diverse phenolic amino acids catalyze the methylation step in the biosynthesis of the actinomycin chromophore</article-title><source>Biochemistry</source><year>2010</year><volume>49</volume><fpage>9698</fpage><lpage>9705</lpage><pub-id pub-id-type="doi">10.1021/bi101422r</pub-id><?supplied-pmid 20945860?><pub-id pub-id-type="pmid">20945860</pub-id></element-citation></ref><ref id="B35-marinedrugs-17-00240"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waters</surname><given-names>C.M.</given-names></name><name><surname>Bassler</surname><given-names>B.L.</given-names></name></person-group><article-title>Quorum sensing: Cell-to-cell communication in bacteria</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2005</year><volume>21</volume><fpage>319</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.21.012704.131001</pub-id><?supplied-pmid 16212498?><pub-id pub-id-type="pmid">16212498</pub-id></element-citation></ref><ref id="B36-marinedrugs-17-00240"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassler</surname><given-names>B.L.</given-names></name><name><surname>Losick</surname><given-names>R.</given-names></name></person-group><article-title>Bacterially speaking</article-title><source>Cell</source><year>2006</year><volume>125</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.04.001</pub-id><?supplied-pmid 16630813?><pub-id pub-id-type="pmid">16630813</pub-id></element-citation></ref><ref id="B37-marinedrugs-17-00240"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>J.L.</given-names></name><name><surname>Mart&#x000ed;nez-Bueno</surname><given-names>M.</given-names></name><name><surname>Molina-Henares</surname><given-names>A.J.</given-names></name><name><surname>Ter&#x000e1;n</surname><given-names>W.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Gallegos</surname><given-names>M.T.</given-names></name><name><surname>Brennan</surname><given-names>R.</given-names></name><name><surname>Tobes</surname><given-names>R.</given-names></name></person-group><article-title>The tetR family of transcriptional repressors</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2005</year><volume>69</volume><fpage>326</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1128/MMBR.69.2.326-356.2005</pub-id><pub-id pub-id-type="pmid">15944459</pub-id></element-citation></ref><ref id="B38-marinedrugs-17-00240"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>H.</given-names></name><name><surname>Ohnishi</surname><given-names>Y.</given-names></name><name><surname>Beppu</surname><given-names>T.</given-names></name><name><surname>Horinouchi</surname><given-names>S.</given-names></name></person-group><article-title>Evolution of <italic>&#x003b3;</italic>-butyrolactone synthases and receptors in Streptomyces</article-title><source>Environ. Microbiol.</source><year>2007</year><volume>9</volume><fpage>1986</fpage><lpage>1994</lpage><pub-id pub-id-type="doi">10.1111/j.1462-2920.2007.01314.x</pub-id><?supplied-pmid 17635544?><pub-id pub-id-type="pmid">17635544</pub-id></element-citation></ref><ref id="B39-marinedrugs-17-00240"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gou</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>A novel tetR family transcriptional regulator, CalR3, negatively controls calcimycin biosynthesis in <italic>Streptomyces chartreusis</italic> NRRL 3882</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>2371</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.02371</pub-id><pub-id pub-id-type="pmid">29238338</pub-id></element-citation></ref><ref id="B40-marinedrugs-17-00240"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Ju</surname><given-names>J.</given-names></name></person-group><article-title>Cloning and characterization of the biosynthetic gene cluster of the bacterial RNA polymerase inhibitor tirandamycin from marine-derived <italic>Streptomyces</italic> sp. SCSIO 1666</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2011</year><volume>406</volume><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.02.040</pub-id><pub-id pub-id-type="pmid">21329667</pub-id></element-citation></ref><ref id="B41-marinedrugs-17-00240"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peschke</surname><given-names>U.</given-names></name><name><surname>Schmidt</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>H.Z.</given-names></name><name><surname>Pieperserg</surname><given-names>W.</given-names></name></person-group><article-title>Molecular characterization of the lincomycin-production gene cluster of <italic>Streptomyces lincolnensis</italic> 78-11</article-title><source>Mol. Microbiol.</source><year>1995</year><volume>16</volume><fpage>1137</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1995.tb02338.x</pub-id><?supplied-pmid 8577249?><pub-id pub-id-type="pmid">8577249</pub-id></element-citation></ref><ref id="B42-marinedrugs-17-00240"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semsary</surname><given-names>S.</given-names></name><name><surname>Crnov&#x0010d;i&#x00107;</surname><given-names>I.</given-names></name><name><surname>Driller</surname><given-names>R.</given-names></name><name><surname>Vater</surname><given-names>J.</given-names></name><name><surname>Loll</surname><given-names>B.</given-names></name><name><surname>Keller</surname><given-names>U.</given-names></name></person-group><article-title>Ketonization of proline residues in the peptide chains of actinomycins by a 4-oxoproline synthase</article-title><source>ChemBioChem</source><year>2018</year><volume>19</volume><fpage>706</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1002/cbic.201700666</pub-id><?supplied-pmid 29327817?><pub-id pub-id-type="pmid">29327817</pub-id></element-citation></ref><ref id="B43-marinedrugs-17-00240"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waksman</surname><given-names>S.A.</given-names></name><name><surname>Woodruff</surname><given-names>H.B.</given-names></name></person-group><article-title>Bacteriostatic and bactericidal substances produced by a soil actinomyces</article-title><source>Exp. Biol. Med.</source><year>1940</year><volume>45</volume><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.3181/00379727-45-11768</pub-id></element-citation></ref><ref id="B44-marinedrugs-17-00240"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gust</surname><given-names>B.</given-names></name><name><surname>Kieser</surname><given-names>T.</given-names></name><name><surname>Chater</surname><given-names>K.</given-names></name></person-group><article-title>PCR targeting system in <italic>Streptomyces coelicolor</italic> A3 (2)</article-title><source>John Innes Centre</source><year>2002</year><volume>3</volume><fpage>1</fpage><lpage>39</lpage></element-citation></ref></ref-list></back><floats-group><fig id="marinedrugs-17-00240-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Gene organization of the actinomycin D cluster in <italic>S. costaricanus</italic> SCSIO ZS0073. The direction of transcription and the proposed functions of individual ORF are indicated.</p></caption><graphic xlink:href="marinedrugs-17-00240-g001"/></fig><fig id="marinedrugs-17-00240-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Proposed model for actinomycin D assembly (<bold>A</bold>) and 4-MHA precursor production (<bold>B</bold>) in <italic>S. costaricanus</italic> SCSIO ZS0073. A: adenylation domain; C: condensation; PCP: peptidyl carrier protein; TE: thioesterase.</p></caption><graphic xlink:href="marinedrugs-17-00240-g002"/></fig><fig id="marinedrugs-17-00240-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>HPLC analysis of <italic>S. costaricanus</italic> strains fermentation extracts. (i) WT producer; (ii) &#x02206;<italic>acnDE</italic> mutant; (iii) &#x02206;<italic>acnN1</italic> mutant; (iv) &#x02206;<italic>acnN3</italic> mutant; (v) &#x02206;<italic>acnGHLM</italic> mutant; (vi) &#x02206;<italic>acnW</italic> mutant; (vii) &#x02206;<italic>acnU4</italic> mutant; (viii) &#x02206;<italic>acnR</italic> mutant; (ix) &#x02206;<italic>acnO</italic> mutant; (x) &#x02206;<italic>acnT1</italic> mutant; (xi) &#x02206;<italic>acnT2</italic> mutant; (xii) &#x02206;<italic>acnT3</italic> mutant. 1, actinomycin D; 2, actinomycin X<italic><sub>o&#x003b2;</sub></italic>.; 3, actinomycin X<sub>2.</sub></p></caption><graphic xlink:href="marinedrugs-17-00240-g003"/></fig><fig id="marinedrugs-17-00240-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>HPLC analyses of <italic>S. costaricanus</italic> strains fermentation extracts. (i) WT producer; (ii) &#x02206;<italic>acnA</italic> mutant; (iii) &#x02206;<italic>acnB</italic> mutant; (iv) &#x02206;<italic>acnC</italic> mutant; (v) &#x02206;<italic>acnU1</italic> mutant; (vi) &#x02206;<italic>acnU2</italic> mutant; (vii) &#x02206;<italic>acnU3</italic> mutant; (viii) &#x02206;<italic>phs</italic> mutant; (ix) &#x02206;<italic>acnQ</italic> mutant; (x) &#x02206;<italic>acnF</italic> mutant. 1, actinomycin D; 2, actinomycin X<italic><sub>o&#x003b2;</sub></italic>.</p></caption><graphic xlink:href="marinedrugs-17-00240-g004"/></fig><fig id="marinedrugs-17-00240-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>HPLC analysis of <italic>S. costaricanus</italic> strains fermentation extracts. (i) WT producer; (ii) &#x02206;<italic>acnP</italic> mutant. 1, actinomycin D; 2, actinomycin X<italic><sub>o&#x003b2;</sub></italic>.</p></caption><graphic xlink:href="marinedrugs-17-00240-g005"/></fig><table-wrap id="marinedrugs-17-00240-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00240-t001_Table 1</object-id><label>Table 1</label><caption><p>Deduced <italic>orf</italic> functions in the <italic>acn</italic> cluster.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Size <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protein Homolog and Origin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ID/SM (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origin (Protein ID)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>orf</italic>(&#x02212;3)</td><td align="center" valign="middle" rowspan="1" colspan="1">492</td><td align="center" valign="middle" rowspan="1" colspan="1">type VII secretion protein EccB</td><td align="center" valign="middle" rowspan="1" colspan="1">96/97</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF88120<break/><italic>Streptomyces</italic> sp. LamerLS-31b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>orf</italic>(&#x02212;2)</td><td align="center" valign="middle" rowspan="1" colspan="1">464</td><td align="center" valign="middle" rowspan="1" colspan="1">type VII secretion integral membrane protein EccD</td><td align="center" valign="middle" rowspan="1" colspan="1">99/99</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF88128<break/><italic>Streptomyces</italic> sp. LamerLS-31b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>orf</italic>(&#x02212;1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1289</td><td align="center" valign="middle" rowspan="1" colspan="1">Collagen triple helix repeat-containing protein</td><td align="center" valign="middle" rowspan="1" colspan="1">53/75</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>Clostridium uliginosum</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnW</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">103</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypothetical protein</td><td align="center" valign="middle" rowspan="1" colspan="1">99/100</td><td align="center" valign="middle" rowspan="1" colspan="1">AB905443.1<break/><italic>Streptomyces rochei</italic> 7434AN4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnA</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">121</td><td align="center" valign="middle" rowspan="1" colspan="1">Protein of unknown function</td><td align="center" valign="middle" rowspan="1" colspan="1">93/96</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF88143<break/><italic>Streptomyces</italic> sp. LamerLS-31b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnB</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">415</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-anti-sigma regulatory factor</td><td align="center" valign="middle" rowspan="1" colspan="1">96/97</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF88151<break/><italic>Streptomyces</italic> sp. LamerLS-31b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnU1</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">121</td><td align="center" valign="middle" rowspan="1" colspan="1">hypothetical protein GA0115258_11557</td><td align="center" valign="middle" rowspan="1" colspan="1">99/100</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF88158<break/><italic>Streptomyces</italic> sp. LamerLS-31b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnU2</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">124</td><td align="center" valign="middle" rowspan="1" colspan="1">hypothetical protein GA0115258_11558</td><td align="center" valign="middle" rowspan="1" colspan="1">95/96</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF88164<break/><italic>Streptomyces</italic> sp. LamerLS-31b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnC</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">392</td><td align="center" valign="middle" rowspan="1" colspan="1">acyl-CoA dehydrogenase</td><td align="center" valign="middle" rowspan="1" colspan="1">91/95</td><td align="center" valign="middle" rowspan="1" colspan="1">AKJ14982<break/><italic>Streptomyces</italic> incarnatus</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnU3</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">207</td><td align="center" valign="middle" rowspan="1" colspan="1">hypothetical protein</td><td align="center" valign="middle" rowspan="1" colspan="1">80/91</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_030987180<break/><italic>Streptomyces</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnU4</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">187</td><td align="center" valign="middle" rowspan="1" colspan="1">hypothetical protein</td><td align="center" valign="middle" rowspan="1" colspan="1">82/88</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_030592054<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnD</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">66</td><td align="center" valign="middle" rowspan="1" colspan="1">protein mbtH</td><td align="center" valign="middle" rowspan="1" colspan="1">91/95</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48080<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnE</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">78</td><td align="center" valign="middle" rowspan="1" colspan="1">4-MHA carrier protein</td><td align="center" valign="middle" rowspan="1" colspan="1">73/85</td><td align="center" valign="middle" rowspan="1" colspan="1">ADG27356<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnN1</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">467</td><td align="center" valign="middle" rowspan="1" colspan="1">Adenylation domain protein</td><td align="center" valign="middle" rowspan="1" colspan="1">51/65</td><td align="center" valign="middle" rowspan="1" colspan="1">SCD96508<break/><italic>Streptomyces</italic> sp. DvalAA-43</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnN2</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2589</td><td align="center" valign="middle" rowspan="1" colspan="1">non-ribosomal peptide synthase</td><td align="center" valign="middle" rowspan="1" colspan="1">73/81</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_057667184<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnN3</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">4249</td><td align="center" valign="middle" rowspan="1" colspan="1">non-ribosomal peptide synthetase</td><td align="center" valign="middle" rowspan="1" colspan="1">78/85</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_064726364<break/><italic>Streptomyces parvulus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnF</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">211</td><td align="center" valign="middle" rowspan="1" colspan="1">hypothetical protein</td><td align="center" valign="middle" rowspan="1" colspan="1">84/88</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48467<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnG</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">326</td><td align="center" valign="middle" rowspan="1" colspan="1">arylformamidase</td><td align="center" valign="middle" rowspan="1" colspan="1">79/85</td><td align="center" valign="middle" rowspan="1" colspan="1">SCF58504<break/><italic>Streptomyces</italic> sp. Cmuel-A718b</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnH</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">284</td><td align="center" valign="middle" rowspan="1" colspan="1">tryptophan 2, 3-dioxygenase</td><td align="center" valign="middle" rowspan="1" colspan="1">84/88</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48467<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnL</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">420</td><td align="center" valign="middle" rowspan="1" colspan="1">kynureninase</td><td align="center" valign="middle" rowspan="1" colspan="1">86/90</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48077<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnM</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">346</td><td align="center" valign="middle" rowspan="1" colspan="1">methyltransferase</td><td align="center" valign="middle" rowspan="1" colspan="1">88/91</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_030594248<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnP</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">386</td><td align="center" valign="middle" rowspan="1" colspan="1">cytochrome P450</td><td align="center" valign="middle" rowspan="1" colspan="1">86/91</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_030594247<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnO</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">224</td><td align="center" valign="middle" rowspan="1" colspan="1">LmbU-like protein</td><td align="center" valign="middle" rowspan="1" colspan="1">73/82</td><td align="center" valign="middle" rowspan="1" colspan="1">ADG27350<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnR</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">282</td><td align="center" valign="middle" rowspan="1" colspan="1">TetR family transcriptional regulator</td><td align="center" valign="middle" rowspan="1" colspan="1">78/86</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48074<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnQ</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">294</td><td align="center" valign="middle" rowspan="1" colspan="1">siderophore-interacting protein</td><td align="center" valign="middle" rowspan="1" colspan="1">78/87</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_030594239<break/><italic>Streptomyces anulatus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnT1</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">346</td><td align="center" valign="middle" rowspan="1" colspan="1">ABC transporter</td><td align="center" valign="middle" rowspan="1" colspan="1">87/92</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48072<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnT2</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">255</td><td align="center" valign="middle" rowspan="1" colspan="1">multidrug ABC transporter permease</td><td align="center" valign="middle" rowspan="1" colspan="1">92/95</td><td align="center" valign="middle" rowspan="1" colspan="1">OOQ48071<break/><italic>Streptomyces antibioticus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>acnT3</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">753</td><td align="center" valign="middle" rowspan="1" colspan="1">UvrABC system protein A</td><td align="center" valign="middle" rowspan="1" colspan="1">60/77</td><td align="center" valign="middle" rowspan="1" colspan="1">AMV28079<break/><italic>Gemmata sp</italic>. SH-PL17</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>orf</italic>(+1)</td><td align="center" valign="middle" rowspan="1" colspan="1">191</td><td align="center" valign="middle" rowspan="1" colspan="1">GCN5-related <italic>N</italic>-acetyltransferase</td><td align="center" valign="middle" rowspan="1" colspan="1">81/87</td><td align="center" valign="middle" rowspan="1" colspan="1">UN35851<break/><italic>Streptomyces venezuelae</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>orf</italic>(+2)</td><td align="center" valign="middle" rowspan="1" colspan="1">109</td><td align="center" valign="middle" rowspan="1" colspan="1">hypothetical protein</td><td align="center" valign="middle" rowspan="1" colspan="1">74/83</td><td align="center" valign="middle" rowspan="1" colspan="1">WP_052876109<break/><italic>Streptomyces sp</italic>. NRRL F-4335</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>orf</italic>(+3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1130</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-component hybrid sensor and regulator</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55/68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SBO98167<break/><italic>Nonomuraea sp</italic>. ATCC 39727</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Size in units of amino acids (aa); ID/SI: identity/similarity; acn: the BGC of actinomycin from <italic>S. costaricanus</italic> SCSIO ZS0073. </p></fn></table-wrap-foot></table-wrap></floats-group></article>